BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Treatment
15 results:

  • 1. Mechanistic actions of long non-coding RNA malat1 within the ovary and at the feto-maternal interface.
    Adu-Gyamfi EA; Cheeran EA; Salamah J; Lee BK
    Mol Biol Rep; 2024 Feb; 51(1):301. PubMed ID: 38353828
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic cancer.
    Jiang W; Du Y; Zhang W; Zhou W
    Can J Gastroenterol Hepatol; 2022; 2022():4661929. PubMed ID: 36406148
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long noncoding RNAs: role and contribution in pancreatic cancer.
    Ramya Devi KT; Karthik D; Mahendran T; Jaganathan MK; Hemdev SP
    Transcription; 2021 Feb; 12(1):12-27. PubMed ID: 34036896
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
    Peng Y; Fang X; Yao H; Zhang Y; Shi J
    Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
    [No Abstract]    [Full Text] [Related]  

  • 5. Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib.
    Eismann J; Heng YJ; Waldschmidt JM; Vlachos IS; Gray KP; Matulonis UA; Konstantinopoulos PA; Murphy CJ; Nabavi S; Wulf GM
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):503-514. PubMed ID: 31745703
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Transcript-level regulation of malat1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
    Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
    Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Long Non-Coding RNAs in Thyroid cancer: Implications for Pathogenesis, Diagnosis, and Therapy.
    Mahmoudian-Sani MR; Jalali A; Jamshidi M; Moridi H; Alghasi A; Shojaeian A; Mobini GR
    Oncol Res Treat; 2019; 42(3):136-142. PubMed ID: 30799425
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Anticancer effects of Rosmarinic acid in OVCAR-3 ovarian cancer cells are mediated via induction of apoptosis, suppression of cell migration and modulation of lncRNA MALAT-1 expression.
    Zhang Y; Hu M; Liu L; Cheng XL; Cai J; Zhou J; Wang T
    J BUON; 2018; 23(3):763-768. PubMed ID: 30003749
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs.
    Hardin H; Helein H; Meyer K; Robertson S; Zhang R; Zhong W; Lloyd RV
    Lab Invest; 2018 Sep; 98(9):1133-1142. PubMed ID: 29967342
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expression of the long non-coding RNA H19 and MALAT-1 in growth hormone-secreting pituitary adenomas and its relationship to tumor behavior.
    Lu T; Yu C; Ni H; Liang W; Yan H; Jin W
    Int J Dev Neurosci; 2018 Jun; 67():46-50. PubMed ID: 29604339
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer.
    Cheng Y; Imanirad P; Jutooru I; Hedrick E; Jin UH; Rodrigues Hoffman A; Leal de Araujo J; Morpurgo B; Golovko A; Safe S
    PLoS One; 2018; 13(2):e0192264. PubMed ID: 29389953
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
    Covach A; Patel S; Hardin H; Lloyd RV
    Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Long non-coding RNA malat1 is up-regulated in ovarian cancer tissue and promotes SK-OV-3 cell proliferation and invasion.
    Zou A; Liu R; Wu X
    Neoplasma; 2016; 63(6):865-872. PubMed ID: 27565324
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.
    Taucher V; Mangge H; Haybaeck J
    Cell Oncol (Dordr); 2016 Aug; 39(4):295-318. PubMed ID: 27060060
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.
    Han T; Jiao F; Hu H; Yuan C; Wang L; Jin ZL; Song WF; Wang LW
    Oncotarget; 2016 Mar; 7(10):11194-207. PubMed ID: 26848980
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.